Senior Director, Therapeutic Area Head, Medical Safety Review, Oncology
The Worldwide Patient Safety group is responsible for ensuring the safety of our medicines: The Worldwide Patient Safety group is responsible for pharmacovigilance and pharmaco-epidemiology deliverables including single case and aggregate safety monitoring, safety reporting, contribution to benefit-risk assessment, risk management planning and strategy, and execution of certain post-marketing commitments and ensuring compliance with global regulatory requirements. Submit resume to mike@advrecinc.com or call for more information 217-457-2222.
|
Director, Medical Safety Assessment Physician, Immunology
The Worldwide Patient Safety (WWPS) group is responsible for ensuring the safety of our medicines. WWPS pharmacovigilance and pharmacoepidemiology deliverables include single case and aggregate safety monitoring, safety reporting, contributing to benefit-risk assessment, risk management planning and strategy, execution of certain post marketing commitments, and ensuring compliance with global regulatory requirements. Submit resume to mike@advrecinc.com or call for more information 217-457-2222.
|
Associate Director Global Risk Management
The Global Risk Management Associate Director, reports to the GRM Lead, for the Therapeutic Area (TA) Immunology, CV, Fibrosis and Mature Products. This role is focused on supporting and leading the development of Global, EU, and Local Market (LM) Risk Management Plans (RMPs), driving LM implementation activities for specific products as directed by the GRM Lead, Immunology, CV, Fibrosis and Mature Products. Submit resume to mike@advrecinc.com or call for more information 217-457-2222.
|
Associate Director, Pharmacovigilance Scientist
Supports Medical Safety Assessment Physicians (MSAP) in leading Safety Data Review (SDR) Teams. Independently performs core signal detection activities and elevate program or portfolio issues impacting key Safety Management Team (SMT) programs, priorities, resources, and milestones. Authors safety data query responses, author and contribute to specific PV sections of the Periodic Benefit Risk Evaluation Report (PBRER) and Development Safety Update Report (DSUR). Ensures pharmacovigilance regulatory compliance. Submit resume to mike@advrecinc.com or call for more information 217-457-2222.
|
|